Gregory A. Korbel
2022
In 2022, Gregory A. Korbel earned a total compensation of $601.3K as Former Chief Operating Officer at Aprea Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $107,292 |
|---|---|
| Option Awards | $128,010 |
| Salary | $310,417 |
| Stock Awards | $55,607 |
| Total | $601,326 |
Korbel received $310.4K in salary, accounting for 52% of the total pay in 2022.
Korbel also received $107.3K in non-equity incentive plan, $128K in option awards and $55.6K in stock awards.
Rankings
In 2022, Gregory A. Korbel's compensation ranked 4,066th out of 5,760 executives tracked by ExecPay. In other words, Korbel earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,066 out of 5,760 | 29th |
Division Manufacturing | 2,297 out of 3,136 | 27th |
Major group Chemicals And Allied Products | 1,115 out of 1,422 | 22nd |
Industry group Drugs | 1,046 out of 1,323 | 21st |
Industry Pharmaceutical Preparations | 767 out of 969 | 21st |
Source: SEC filing on July 11, 2023.
Korbel's colleagues
We found four more compensation records of executives who worked with Gregory A. Korbel at Aprea Therapeutics in 2022.